BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12653561)

  • 1. Regulation of c-Fes tyrosine kinase activity by coiled-coil and SH2 domains: analysis with Saccharomyces cerevisiae.
    Takashima Y; Delfino FJ; Engen JR; Superti-Furga G; Smithgall TE
    Biochemistry; 2003 Apr; 42(12):3567-74. PubMed ID: 12653561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
    Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
    Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.
    Cheng H; Rogers JA; Dunham NA; Smithgall TE
    Mol Cell Biol; 1999 Dec; 19(12):8335-43. PubMed ID: 10567558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.
    Cheng HY; Schiavone AP; Smithgall TE
    Mol Cell Biol; 2001 Sep; 21(18):6170-80. PubMed ID: 11509660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligomerization of the Fes tyrosine kinase. Evidence for a coiled-coil domain in the unique N-terminal region.
    Read RD; Lionberger JM; Smithgall TE
    J Biol Chem; 1997 Jul; 272(29):18498-503. PubMed ID: 9218495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human c-Fes tyrosine kinase binds tubulin and microtubules through separate domains and promotes microtubule assembly.
    Laurent CE; Delfino FJ; Cheng HY; Smithgall TE
    Mol Cell Biol; 2004 Nov; 24(21):9351-8. PubMed ID: 15485904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET; Gahmberg CG
    J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.
    Lionberger JM; Smithgall TE
    Cancer Res; 2000 Feb; 60(4):1097-103. PubMed ID: 10706130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
    Lerner EC; Smithgall TE
    Nat Struct Biol; 2002 May; 9(5):365-9. PubMed ID: 11976726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
    Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G
    J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSH2: a novel SH2 domain-containing adapter protein involved in tyrosine kinase signaling in hematopoietic cells.
    Oda T; Muramatsu MA; Isogai T; Masuho Y; Asano S; Yamashita T
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1078-86. PubMed ID: 11700021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophosphorylation of the Fes tyrosine kinase. Evidence for an intermolecular mechanism involving two kinase domain tyrosine residues.
    Rogers JA; Read RD; Li J; Peters KL; Smithgall TE
    J Biol Chem; 1996 Jul; 271(29):17519-25. PubMed ID: 8663427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase.
    Delfino FJ; Shaffer JM; Smithgall TE
    Biochem J; 2006 Oct; 399(1):141-50. PubMed ID: 16792528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, purification and preliminary crystallographic studies on the catalytic region of the nonreceptor tyrosine kinase Fes.
    Gnemmi I; Scotti C; Cappelletti D; Canonico PL; Condorelli F; Rosano C
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jan; 63(Pt 1):18-20. PubMed ID: 17183165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of the ras GTPase-activating protein (GAP) by the p93c-fes protein-tyrosine kinase in vitro and formation of GAP-fes complexes via an SH2 domain-dependent mechanism.
    Hjermstad SJ; Briggs SD; Smithgall TE
    Biochemistry; 1993 Oct; 32(39):10519-25. PubMed ID: 7691175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M; Rohner D; Bichsel S
    Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncation of c-fes via gene targeting results in embryonic lethality and hyperproliferation of hematopoietic cells.
    Hackenmiller R; Simon MC
    Dev Biol; 2002 May; 245(2):255-69. PubMed ID: 11977979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation.
    Tagliafico E; Siena M; Zanocco-Marani T; Manfredini R; Tenedini E; Montanari M; Grande A; Ferrari S
    Oncogene; 2003 Mar; 22(11):1712-23. PubMed ID: 12642874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.